Immunoparesis in Newly Diagnosed Multiple Myeloma and Its Impact on Clinical Outcome: A Real-World Experience

被引：0
|
作者：
Mahapatra, Manoranjan [1 ]
Verghese, Renjith Mathew [2 ]
Dhawan, Rishi [1 ]
Das, Jasmita [1 ]
Aggarwal, Mukul [1 ]
Kumar, Pradeep [1 ]
Kumar, Ganesh [1 ]
Seth, Tulika [1 ]
机构：
[1] AIIMS, New Delhi, India
[2] AFMC, Pune, Maharashtra, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
MM; immunoparesis; multiple myeloma; infection;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-681
引用
收藏
页码：S579 / S579
页数：1
相关论文
共 50 条
  • [41] Risk factors and causes of early mortality in patients with newly diagnosed multiple myeloma in a "real-world" study: experiences of the Polish Myeloma Group
    Charlinski, Grzegorz
    Tyczynska, Agata
    Malecki, Bartosz
    Fornagiel, Szymon
    Barchnicka, Agnieszka
    Kolkowska, Agnieszka
    Kopinska, Anna
    Usnarska-Zubkiewicz, Lidia
    Robak, Pawel
    Waszczuk-Gajda, Anna
    Krzystanski, Mateusz
    Jurczyszyn, Artur
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (06): : 527 - 534
  • [42] Real-world Experience of Niraparib in Newly-diagnosed Epithelial Ovarian Cancer
    Shin, Wonkyo
    Noh, Joseph J.
    Baek, Seung Hun
    Kim, Byoung-Gie
    Lim, Myong Cheol
    Park, Sang-Yoon
    ANTICANCER RESEARCH, 2021, 41 (09) : 4603 - 4607
  • [43] REAL-WORLD DATA ON MULTIPLE MYELOMA: A PROSPECTIVE NATIONAL REGISTRY IN URUGUAY ON 224 NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS FROM 2012-2015
    Riva, E.
    Bove, V.
    Villano, F.
    Mori, M.
    Noria, A.
    Petruskevicius, P.
    Cordoba, C.
    Cardeza, A.
    Diaz, L.
    HAEMATOLOGICA, 2017, 102 : 522 - 522
  • [44] Clinical treatment of newly diagnosed multiple myeloma
    Cejalvo, Maria J.
    de la Rubia, Javier
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (05) : 595 - 611
  • [45] Real-World Utilization of Daratumumab-Containing Induction Regimen in Transplant Eligible Newly Diagnosed Multiple Myeloma and Its Role in Patients Historically Excluded from Clinical Trials: A Single Institution Experience
    Biltibo, Eden Ayele
    Kassim, Adetola A.
    BLOOD, 2023, 142
  • [46] Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
    Jew, Scott
    Bujarski, Sean
    Regidor, Bernard
    Emamy-Sadr, Marsiye
    Swift, Regina
    Eades, Benjamin
    Kim, Susanna
    Eshaghian, Shahrooz
    Berenson, James R.
    TARGETED ONCOLOGY, 2023, 18 (05) : 735 - 747
  • [47] Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
    Scott Jew
    Sean Bujarski
    Bernard Regidor
    Marsiye Emamy-Sadr
    Regina Swift
    Benjamin Eades
    Susanna Kim
    Shahrooz Eshaghian
    James R. Berenson
    Targeted Oncology, 2023, 18 : 735 - 747
  • [48] Outcome of elderly patients with newly diagnosed multiple myeloma depending on the eligibility for clinical trials: a single institution experience
    Tovar, Natalia
    Gerardo Rodriguez-Lobato, Luis
    Jimenez, Raquel
    Esteban, Daniel
    Triguero, Ana
    Cibeira Lopez, M. Teresa
    Pereira, Arturo
    Rosinol, Laura
    Blade, Joan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E237 - E237
  • [49] Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
    Hoff, Fieke W.
    Banerjee, Rahul
    Khan, Adeel M.
    McCaughan, Georgia
    Wang, Bo
    Wang, Xiaoliang
    Roose, James
    Anderson Jr, Larry D.
    Cowan, Andrew J.
    Rajkumar, S. Vincent
    Kaur, Gurbakhash
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [50] A glimpse into transplant-ineligible newly diagnosed multiple myeloma treatment in real-world practice in Spain: carinae study
    de Arriba de la Fuente, Felipe
    Hernandez Garcia, Miguel Teodoro
    Soler Campos, Juan Alfons
    Herraez Rodriguez, Susana
    Jose Moreno, Ma
    Conzalez Pardo, Miriam
    Gironella Mesa, Mercedes
    Casanova Espinosa, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S143 - S144
12345